How do consumers perceive differences in risk across nicotine products? A review of relative risk perceptions across smokeless tobacco, e-cigarettes, nicotine replacement therapy and combustible cigarettes

Czoli, Christine D; Fong, Geoffrey T.; Mays, Darren; Hammond, David

doi:10.1136/tobaccocontrol-2016-053060

Cited by 99 publications

(100 citation statements)

References 82 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our starting point for the simulation analysis is a scenario which we believe to approximate the state of the world at the time our DCE was conducted (2015). We define the state of the world as follows: e‐cigarettes are considered to be healthier than tobacco cigarettes by 70% of adults (Czoli et al ), e‐cigarettes are considered to be an effective cessation device by 33% of adults (Tan, Lee, and Bigman ), use of e‐cigarettes in public places is allowed in most states, and there is no e‐cigarettes tax . To implement assumptions regarding health and effectiveness as cessation device, 70% and 33% of respondents in our sample were randomly assigned a value of one for the corresponding attribute .…”

Section: Simulationsmentioning

confidence: 99%

To “Vape” or Smoke? Experimental Evidence on Adult Smokers

et al. 2018

View full text Add to dashboard Cite

A growing share of the United States population uses e-cigarettes but the optimal regulation of these controversial products remains an open question. We conduct a discrete choice experiment to investigate how adult tobacco cigarette smokers’ demand for e-cigarettes and tobacco cigarettes varies by four attributes: (i) whether e-cigarettes are considered healthier than tobacco cigarettes, (ii) the effectiveness of e-cigarettes as a cessation device, (iii) bans on use in public places, and (iv) price. We find that adult smokers’ demand for e-cigarettes is motivated more by health concerns than by the desire to avoid smoking bans or higher prices.

show abstract

Section: Simulationsmentioning

confidence: 99%

To “Vape” or Smoke? Experimental Evidence on Adult Smokers

et al. 2018

View full text Add to dashboard Cite

show abstract

“…In a review paper, Czoli et al 12 report that substantial proportions of respondents in 54 studies reported inaccurate beliefs about the relative harmfulness of smokeless tobacco versus combustible cigarettes. This has important ramifications given the history of ‘no safe tobacco product’ messages that have long been promoted by health authorities, particularly in the USA.…”

mentioning

confidence: 99%

Conflicts and controversies in contemporary tobacco control

Malone

2017

Tob Control

View full text Add to dashboard Cite

“…Additionally, there is a need for health professionals to challenge black and white thinking around smoking and quitting that serves to support smoking behaviour. Even among those who appeared interested in quitting smoking, there was a tendency to overemphasize the negative health, financial, effectiveness and lifestyle elements of alternatives to smoking in their deliberations [33]. While an idealisation of becoming a healthful and thrifty non-smoker appears to be part of what motivates some participants to want to quit, it also works against those who may struggle to quit smoking without assistance and/or may not be able to quit nicotine.…”

Section: Discussionmentioning

confidence: 99%

Views and Preferences for Nicotine Products as an Alternative to Smoking: A Focus Group Study of People Living with Mental Disorders

Ford

Sharma

Fitzgerald

et al. 2016

IJERPH

View full text Add to dashboard Cite

Aims and Background: People living with mental disorders experience a disproportionately higher burden of tobacco-related disease than the general population. Long-term substitution with less harmful nicotine products could reduce the tobacco-related harm among this population. This study investigated the views and preferences of people with mental health disorders about different nicotine products and their use as long-term substitutes for cigarettes. Methods: Semi-structured focus group discussion followed by a brief questionnaire. The discussion transcripts were analysed for content and themes and quantitative data summarised with descriptive statistics. Results: Twenty-nine participants took part in four focus groups. Vaping devices were the most acceptable nicotine products discussed; however preferences for nicotine products were individual and varied along aesthetic, pragmatic, sensory and symbolic dimensions. The concept of tobacco harm reduction was unfamiliar to participants, however they generally agreed with the logic of replacing cigarettes with less harmful nicotine products. Barriers to activating tobacco harm reduction included the symbolism of smoking and quitting; the importance placed on health; the consumer appeal of alternatives; and cost implications. Discussion and Conclusions: Engaging this population in tobacco harm reduction options will require communication that challenges black and white thinking (a conceptual framework in which smoking cigarettes or quitting all nicotine are the only legitimate options) as in practice this serves to support the continuance of smoking. Consumers should be encouraged to trial a range of nicotine products to find the most acceptable alternative to smoking that reduces health harms. Providing incentives to switch to nicotine products could help overcome barriers to using less harmful nicotine products among mental health consumers.

show abstract

How do consumers perceive differences in risk across nicotine products? A review of relative risk perceptions across smokeless tobacco, e-cigarettes, nicotine replacement therapy and combustible cigarettes

Cited by 99 publications

References 82 publications

To “Vape” or Smoke? Experimental Evidence on Adult Smokers

To “Vape” or Smoke? Experimental Evidence on Adult Smokers

Conflicts and controversies in contemporary tobacco control

Views and Preferences for Nicotine Products as an Alternative to Smoking: A Focus Group Study of People Living with Mental Disorders

Contact Info

Product

Resources

About